QMS Medical Allied Services enterprise value

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025
334——
6.76.74.3
9.89.817.4
Reference items — trailing FY values
267173156
40.925.925.4
34.521.921.6
—19.420.1
13.713.7−28.2
—12.0−28.8
—5.848.3
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

QMSMEDI₹172.77

QMS Medical Allied Services Limited

· Pharma & Health
₹ CroreMcap ₹334 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization——334.1
- Cash, Equiv & ST Investments4.36.76.7
+ Minority Interest17.49.89.8
Reference Items — Trailing FY Values
Sales156.0172.9267.0
EBITDA25.425.940.9
EBIT21.621.934.5
Operating Cash Flow20.119.4—
Free Cash Flow-28.213.713.7
FCFF (free cash flow to the firm)-28.812.0—
Capital Expenditure48.35.8—
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.